Published: January 03, 2013
AllCells Releases New Line of Bioservices
EMERYVILLE, Calif., Jan. 3, 2013 /PRNewswire/ -- AllCells LLC, a leading provider of healthy & diseased hematopoietic tissues and related services to the global life science industry is proud to announce the release of a new line of Bioservices. The CRO type of Bioservices will be focusing on drug discovery, preclinical research, drug toxicity assays, and other life science research applications.
-- ELISA (single, multiplex)
-- Cell Based Assays
-- Luminex Assays (single, multiplex)
Stem Cell Assays
-- Hematopoietic Stem Cell Based Assays
-- Colony Forming Assays (CFU assays)
-- CFU-M, CFU-GM, CFU-G, BFU-E
-- Mesenchymal Stem Cell Based Assays
-- CFU-F, osteoblast, chondrocyte and adipocyte differentiation
Flow Cytometry Services
To read the complete release at NewsBlaze,
AllCells Releases New Line of Bioservices,
Related PRNewswire Releases News
AJC welcomed a new Israeli government report on Muhammad al-Durrah as an important contribution to understanding the events that transpired in Gaza in September 2000. The 12-year-old Palestinian boy reportedly died during a gun battle between ...
Takes highest honor at the prestigious ICSC VIVA Awards
Qihoo 360 Technology Co. Ltd. , a leading Internet company in China, today reported its unaudited financial results for the quarter ended March 31, 2013.
'Hating Breitbart' Outsells New Documentaries from Ken Burns, Rihanna and Rolling Stones
At Vicenzaoro Spring Andrea Palladio International Jewellery Awards, the Jewellery Oscars
European Internet Users Urge Regulators to 'Rein in Google' on Privacy Concerns